<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pharmacotherapy for chronic cognitive impairment in traumatic brain injury - Dougall, D - 2015 | Cochrane Library</title> <meta content="Pharmacotherapy for chronic cognitive impairment in traumatic brain injury - Dougall, D - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009221.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pharmacotherapy for chronic cognitive impairment in traumatic brain injury - Dougall, D - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009221.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009221.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Pharmacotherapy for chronic cognitive impairment in traumatic brain injury" name="citation_title"/> <meta content="Dominic Dougall" name="citation_author"/> <meta content="East London NHS Foundation Trust" name="citation_author_institution"/> <meta content="Norman Poole" name="citation_author"/> <meta content="East London NHS Foundation Trust" name="citation_author_institution"/> <meta content="Norman.poole@eastlondon.nhs.uk" name="citation_author_email"/> <meta content="Niruj Agrawal" name="citation_author"/> <meta content="St George's Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD009221.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/12/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009221.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009221.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009221.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Atomoxetine Hydrochloride [therapeutic use]; Benzhydryl Compounds [therapeutic use]; Brain Injuries [*complications]; Chronic Disease; Cognition [drug effects]; Cognition Disorders [*drug therapy, etiology]; Modafinil; Nootropic Agents [*therapeutic use]; Piperidines [therapeutic use]; Randomized Controlled Trials as Topic; Rivastigmine [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009221.pub2&amp;doi=10.1002/14651858.CD009221.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="IregKd2C";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009221\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009221\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009221.pub2",title:"Pharmacotherapy for chronic cognitive impairment in traumatic brain injury",firstPublishedDate:"Dec 1, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Dementia and Cognitive Improvement Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IregKd2C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009221.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009221.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009221.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009221.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009221.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009221.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009221.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009221.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009221.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009221.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3675 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009221.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-sec-0063"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-sec-0045"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-sec-0057"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/appendices#CD009221-sec-0068"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/table_n/CD009221StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/table_n/CD009221StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pharmacotherapy for chronic cognitive impairment in traumatic brain injury</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information#CD009221-cr-0002">Dominic Dougall</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information#CD009221-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Norman Poole</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information#CD009221-cr-0004">Niruj Agrawal</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information/en#CD009221-sec-0073">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 December 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009221.pub2">https://doi.org/10.1002/14651858.CD009221.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009221-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009221-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009221-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009221-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009221-abs-0001" lang="en"> <section id="CD009221-sec-0001"> <h3 class="title" id="CD009221-sec-0001">Background</h3> <p>Traumatic brain injury (TBI) is a major cause of chronic disability. Worldwide, it is the leading cause of disability in the under 40s, resulting in severe disability in some 150 to 200 million people per annum. In addition to mood and behavioural problems, cognition—particularly memory, attention and executive function—are commonly impaired by TBI. Cognitive problems following TBI are one of the most important factors in determining people's subjective well‐being and their quality of life. Drugs are widely used in an attempt to improve cognitive functions. Whilst cholinergic agents in TBI have been reviewed, there has not yet been a systematic review or meta‐analysis of the effect on chronic cognitive problems of all centrally acting pharmacological agents. </p> </section> <section id="CD009221-sec-0002"> <h3 class="title" id="CD009221-sec-0002">Objectives</h3> <p>To assess the effects of centrally acting pharmacological agents for treatment of chronic cognitive impairment subsequent to traumatic brain injury in adults. </p> </section> <section id="CD009221-sec-0003"> <h3 class="title" id="CD009221-sec-0003">Search methods</h3> <p>We searched ALOIS—the Cochrane Dementia and Cognitive Improvement Group’s Specialised Register—on 16 November 2013, 23 February 2013, 20 January 2014, and 30 December 2014 using the terms: traumatic OR TBI OR "brain injury" OR "brain injuries" OR TBIs OR "axonal injury" OR "axonal injuries". ALOIS contains records of clinical trials identified from monthly searches of a number of major healthcare databases, numerous trial registries and grey literature sources. Supplementary searches were also performed in MEDLINE, EMBASE, PsycINFO, <i>The Cochrane Library</i>, CINAHL, LILACs, ClinicalTrials.gov, the World Health Organization (WHO) Portal (ICTRP) and Web of Science with conference proceedings. </p> </section> <section id="CD009221-sec-0004"> <h3 class="title" id="CD009221-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) assessing the effectiveness of any one centrally acting pharmacological agent that affects one or more of the main neurotransmitter systems in people with chronic traumatic brain injury; and there had to be a minimum of 12 months between the injury and entry into the trial. </p> </section> <section id="CD009221-sec-0005"> <h3 class="title" id="CD009221-sec-0005">Data collection and analysis</h3> <p>Two review authors examined titles and abstracts of citations obtained from the search. Relevant articles were retrieved for further assessment. A bibliographic search of relevant papers was conducted. We extracted data using a standardised tool, which included data on the incidence of adverse effects. Where necessary we requested additional unpublished data from study authors. Risk of bias was assessed by a single author. </p> </section> <section id="CD009221-sec-0006"> <h3 class="title" id="CD009221-sec-0006">Main results</h3> <p>Only four studies met the criteria for inclusion, with a total of 274 participants. Four pharmacological agents were investigated: modafinil (51 participants); (−)‐OSU6162, a monoamine stabiliser (12 participants of which six had a TBI); atomoxetine (60 participants); and rivastigmine (157 participants). A meta‐analysis could not be performed due to the small number and heterogeneity of the studies. </p> <p>All studies examined cognitive performance, with the majority of the psychometric sub‐tests showing no difference between treatment and placebo (n = 274, very low quality evidence). For (−)‐OSU6162 modest superiority over placebo was demonstrated on three measures, but markedly inferior performance on another. Rivastigmine was better than placebo on one primary measure, and a single cognitive outcome in a secondary analysis of a subgroup with more severe memory impairment at baseline. The study of modafinil assessed clinical global improvement (n = 51, low quality evidence), and did not find any difference between treatment and placebo. Safety, as measured by adverse events, was reported by all studies (n = 274, very low quality evidence), with significantly more nausea reported by participants who received rivastigmine compared to placebo. There were no other differences in safety between treatment and placebo. No studies reported any deaths. </p> </section> <section id="CD009221-sec-0007"> <h3 class="title" id="CD009221-sec-0007">Authors' conclusions</h3> <p>There is insufficient evidence to determine whether pharmacological treatment is effective in chronic cognitive impairment in TBI. Whilst there is a positive finding for rivastigmine on one primary measure, all other primary measures were not better than placebo. The positive findings for (−)‐OSU6162 are interpreted cautiously as the study was small (n = 6). For modafinil and atomoxetine no positive effects were found. All four drugs appear to be relatively well tolerated, although evidence is sparse. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009221-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009221-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009221-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009221-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD009221-abs-0004">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009221-abs-0003" lang="en"> <h3>Drug treatments for chronic cognitive impairment in traumatic brain injury</h3> <p>Background: Traumatic brain injury (TBI) is a major cause of long‐term disability across the world. The disability is often related to chronic cognitive impairment, such as changes to memory, attention and problem solving. </p> <p>Method: We reviewed randomised controlled trials investigating the efficacy of any of the drugs commonly used to treat cognitive impairment after TBI. We included only studies which started treatment at least 12 months after the injury; by this time the cognitive impairment is usually stable. </p> <p>Results: We identified only four trials for inclusion. These investigated four different drugs—modafinil; the experimental drug (−)‐OSU6162; atomoxetine; and rivastigmine—against placebo. On most measures there was no difference between treatment and placebo. Furthermore, the quality of the evidence was assessed as very low. </p> <p>The experimental drug called (−)‐OSU6162 was better than placebo on three cognitive measures, although this was a small study with only six participants with TBI. Modafinil, atomoxetine and rivastigmine were not found to be better than placebo. No difference between modafinil and placebo was found on assessment of clinical global improvement. Compared to placebo, more participants on modafinil and fewer on rivastigmine dropped out of the trials. More people taking modafinil, atomoxetine and rivastigmine experienced adverse effects than those on placebo, although the difference is most likely due to chance. Only nausea was statistically more likely in those taking rivastigmine. In the study of (−)‐OSU6162, one participant of three given placebo experienced adverse effects requiring a dose reduction, with no drop‐outs reported. No studies reported any deaths. </p> <p>Conclusion: Recommendations for, or against, drug treatment of chronic cognitive impairment in TBI cannot be made on the basis of current evidence. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009221-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009221-sec-0063"></div> <h3 class="title" id="CD009221-sec-0064">Implications for practice</h3> <section id="CD009221-sec-0064"> <p>Recommendations for the pharmacological treatment of chronic cognitive impairment in TBI cannot be made on the basis of RCT evidence despite a pharmacodynamic rationale, as disruption of cholinergic systems secondary to brain injury has been demonstrated (<a href="./references#CD009221-bbs2-0030" title="HeilmanKM , WatsonRT , ValensteinE . Neglect and related disorders. In: KMHeilman , EValenstein editor(s). Clinical Neuropsychology. New York: Oxford University Press, 1993:279‐336. ">Heilman 1993</a>; <a href="./references#CD009221-bbs2-0050" title="TenovuoOS . Cholinergic treatment of traumatic brain injury. Current Drug Therapy2006;1(2):187‐209. ">Tenovuo 2006</a>; <a href="./references#CD009221-bbs2-0014" title="ArciniegasD , AdlerL , TopkoffJ , CawthraE , FilleyCM , ReiteM . Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Injury1999;13(1):1‐13. ">Arciniegas 1999</a>). Potential benefits of treatments, even if modest, might still be considered in the context of the high prevalence (<a href="./references#CD009221-bbs2-0025" title="FlemingerS , PonsfordJ . Long term outcome after traumatic brain injury. British Medical Journal2005;331(7530):1419‐20. ">Fleminger 2005</a>), and substantial disability associated with TBI (<a href="./references#CD009221-bbs2-0051" title="ThornhillS , TeasdaleGM , MurrayGD , McEwenJ , RoyCW , PennyKI . Disability in young people and adults one year after head injury: prospective cohort study. British Medical Journal2000;320(7250):1631‐5. ">Thornhill 2000</a>). In addition, there is no RCT evidence recommending against the use of pharmacological treatments which seem safe and well tolerated and the costs are reducing (with drugs such as donepezil, galantamine and rivastigmine coming off patent). </p> <p>The absence of clinical effectiveness of centrally acting pharmacological agents is in contrast to the developing evidence base for rehabilitative techniques such as environmental adaptations, errorless learning, external memory aids and retrieval stratagems recommended by experts in the field (<a href="./references#CD009221-bbs2-0055" title="WilsonBA . Management and remediation of memory problems in brain‐injured adults. The Handbook of Memory Disorders. 2nd Edition. John Wiley &amp; Sons, 2002:655‐82. ">Wilson 2002</a>). The benefits of cognitive rehabilitation have also been supported by a recent review (<a href="./references#CD009221-bbs2-0038" title="LuJ , GaryKW , NeimeierJP , WardJ , LapaneKL . Randomized controlled trials in adult traumatic brain injury. Brain Injury2012;26(13‐14):1523‐48. ">Lu 2012</a>). </p> </section> <h3 class="title" id="CD009221-sec-0065">Implications for research</h3> <section id="CD009221-sec-0065"> <p>This review demonstrates the need for further RCTs to investigate the effectiveness of pharmacological treatments for chronic cognitive impairment in adults with traumatic brain injury. Future RCTs investigating cognitive impairment in chronic TBI in adults should define the severity of TBI, the degree of cognitive impairment at baseline, with inclusion only of participants who sustained TBI more than 12 months before. Studies are needed to determine the efficacy and acceptability of all of the types of interventions that this review sought to investigate, to include antidepressants, antipsychotics, dopamine agonists, cholinergics and psychostimulants compared to placebo. In assessing outcomes, in addition to the use of validated measures to assess global severity of cognitive impairment and memory performance, assessment of neurobehavioural symptoms of TBI, such as personality change and dysexecutive syndrome may be particularly worthwhile, as such symptoms may have profound adverse impact on both social and occupational functioning, and therefore illness burden. </p> <p>An updated search of the literature is recommended in five years.</p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009221-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009221-sec-0015"></div> <div class="table" id="CD009221-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pharmacological agents compared to placebo for chronic cognitive impairment in traumatic brain injury</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Modafanil, (−)‐OSU6162, atomoxetine or rivastigmine compared to placebo for chronic cognitive impairment in traumatic brain injury</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with chronic cognitive impairment in traumatic brain injury<br/> <b>Settings:</b> Inpatient or community<br/> <b>Intervention:</b> Drug treatment<br/> <b>Comparison:</b> Placebo (2 to 10 weeks) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Effect of drug treatment for people with cognitive impairment in traumatic brain injury</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cognitive performance on psychometric tests</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The majority of sub‐tests showed no difference between treatment and placebo.</p> <p>Superiority over placebo was shown in one measure in <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> and several measures in <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a> and <a href="./references#CD009221-bbs2-0005" title="JohanssonB , WentzelA‐P , AndréllP , MannheimerC , RönnbäckL . Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury. Brain Injury2015;29(6):758‐65. ">Johansson 2015</a>. However, interpretation of these findings are cautioned. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>274 (4 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data synthesis was not possible due to the heterogeneity of studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical global improvement</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>A single study reported no difference between treatment and placebo.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p>low<sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data synthesis was not possible as only one study reported a measure on clinical global improvement. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Acceptability</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No differences between treatment and placebo were found.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274(4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>very low<sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data synthesis was not possible due to the heterogeneity of studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Safety</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>More nausea was reported in participants receiving rivastigmine than placebo (<a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a>). No other differences were found. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>very low<sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data synthesis was not possible due to the heterogeneity of studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No deaths were reported by any study.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not estimable.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> downgraded one level due to serious indirectness, as two of four studies did not investigate cognitive impairment as a primary outcome </p> <p><sup>2</sup> downgraded one level due to serious inconsistency, due to wide variance of point estimates. </p> <p><sup>3</sup> downgraded one level due to serious imprecision, as the total population size was less than 400. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009221-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009221-sec-0016"></div> <section id="CD009221-sec-0017"> <h3 class="title" id="CD009221-sec-0017">Description of the condition</h3> <p>Traumatic brain injury (TBI) can result from closed‐head injury, penetrating‐head injury or a combination thereof. Penetrating‐head injury can affect any region of the brain while closed‐head injury, which includes rapid acceleration‐deceleration injury, can result in focal lesions but always causes diffuse damage. Diffuse damage consists of a combination of one or more of diffuse axonal injury (DAI), hypoxic brain damage, vascular injury, and swelling (<a href="./references#CD009221-bbs2-0012" title="AdamsJH , GrahamDI , GennarelliTA , MaxwellWL . Diffuse axonal injury due to non‐missile head injury. Journal of Neurology, Neurosurgery, and Psychiatry1991;54(6):481‐3. ">Adams 1991</a>), which frequently involve the white matter of the frontal lobes, the corpus callosum and the corona radiata (<a href="./references#CD009221-bbs2-0026" title="GentryLR , GoderskyJC , ThompsonB . MR imaging of head trauma: review of the distributions and radiopathologic features of traumatic lesions. American Journal of Roentgenology1988;150(3):663‐72. ">Gentry 1988</a>). TBI varies widely in its severity. The commonest form, mild TBI, by definition, is associated with altered mental state at the time of injury; either no or brief (under 30 minutes) loss of consciousness; Glasgow Coma Scale score 13 to 15 after 30 minutes; and post‐traumatic amnesia less than 24 hours (<a href="./references#CD009221-bbs2-0034" title="KayT , HarringtonDE , AdamsR , AndersonT , BerrolS , CiceroneK , et al. Definition of mild traumatic brain injury. Journal of Head Trauma Rehabilitation1993;8(3):86‐7. ">Kay 1993</a>). Mild TBI therefore encompasses a broad spectrum of severities, from feeling momentarily dazed following the trauma to 30 minutes loss of consciousness requiring hospital admission. In severe TBI the loss of consciousness or post‐traumatic amnesia can persist for one week or longer, sometimes even weeks to months (<a href="./references#CD009221-bbs2-0047" title="SilverJM , HalesRE , YudofskySC . Neuropsychiatric aspects of traumatic brain injury. In: S.C.Yudofsky , R.E.Hales editor(s). The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioural Neurosciences. 5th Edition. Washington, DC: American Psychiatric Publishing, Inc., 2008:595‐647. ">Silver 2008</a>). </p> <p>TBI is a major cause of chronic disability, even following mild injury (<a href="./references#CD009221-bbs2-0051" title="ThornhillS , TeasdaleGM , MurrayGD , McEwenJ , RoyCW , PennyKI . Disability in young people and adults one year after head injury: prospective cohort study. British Medical Journal2000;320(7250):1631‐5. ">Thornhill 2000</a>). Worldwide, it is the leading cause of disability in the under 40s, resulting in severe disability in some 150 to 200 million people per annum (<a href="./references#CD009221-bbs2-0025" title="FlemingerS , PonsfordJ . Long term outcome after traumatic brain injury. British Medical Journal2005;331(7530):1419‐20. ">Fleminger 2005</a>). Neuropsychiatric sequelae of varying severity (which include problems with attention, arousal, concentration, executive functioning, memory impairment, personality change, affective disorders, anxiety, psychosis, aggression and irritability), occur in over two‐thirds of survivors while the vulnerability for such complications can persist for decades (<a href="./references#CD009221-bbs2-0035" title="KoponenS , TaiminenT , PortinR , HimanenL , IsoniemiH , HeinonenH , et al. Axis I and II psychiatric disorders after traumatic brain injury: a 30‐year follow‐up study. American Journal of Psychiatry2002;159(8):1315‐21. ">Koponen 2002</a>; <a href="./references#CD009221-bbs2-0032" title="HimanenL , PortinR , IsoniemiH , HeleniusH , KurkiT , TenovuoO . Longitudinal cognitive changes in traumatic brain injury: a 30‐year follow‐up study. Neurology2006;66(2):187‐92. ">Himanen 2006</a>; <a href="./references#CD009221-bbs2-0047" title="SilverJM , HalesRE , YudofskySC . Neuropsychiatric aspects of traumatic brain injury. In: S.C.Yudofsky , R.E.Hales editor(s). The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioural Neurosciences. 5th Edition. Washington, DC: American Psychiatric Publishing, Inc., 2008:595‐647. ">Silver 2008</a>). The majority of those with mild TBI show significant improvement of their symptoms over the first 6 months (<a href="./references#CD009221-bbs2-0015" title="BernsteinDM . Recovery from mild head injury. Brain Injury1999;13(3):151‐72. ">Bernstein 1999</a>); but if symptoms have not resolved by 6 to 12 months, they tend to persist (<a href="./references#CD009221-bbs2-0017" title="BrownSJ , FannJR , GrantI . Postconcussional disorder: time to acknowledge a common source of neurobehavioural morbidity. The Journal of Neuropsychiatry and Clinical Neuroscience1994;6(1):15‐22. ">Brown 1994</a>). Those with moderate to severe TBI show significant improvement of cognitive function over the first year following injury (<a href="./references#CD009221-bbs2-0048" title="TabaddorK , MattisS , Zazula . Cognitive sequelae and recovery course after moderate and severe head injury. Neurosurgery1984;14(6):701‐8. ">Tabaddor 1984</a>), but improvement appears to plateau by the end of year two (<a href="./references#CD009221-bbs2-0054" title="WhyteJ , Nakase‐RichardsonR , HammondFM , McNameeS , GiacinoJT , KalmarK , et al. Functional outcomes in traumatic disorders of consciousness: 5‐year outcomes from the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems. Archives of Physical Medicine and Rehabilitation2013;94(10):1855‐60. ">Whyte 2013</a>). </p> <p>In addition to mood and behavioural problems, memory, attention and executive function are commonly impaired by TBI (<a href="./references#CD009221-bbs2-0037" title="Lippert‐GrunerM , KuchtaJ , HellmichM , KlugN . Neurobehavioural deficits after severe traumatic brain injury (TBI). Brain Injury2006;20(6):569‐74. ">Lippert‐Gruner 2006</a>), and prove difficult to remedy (<a href="./references#CD009221-bbs2-0044" title="SalazarAM , WardenDL , SchwabK , SpectorJ , BravermanS , WalterJ , et al. Cognitive rehabilitation for traumatic brain injury: a randomized trial. Journal of the American Medical Association2000;283(23):3075‐81. ">Salazar 2000</a>). Selective attention, the attending to chosen information at the expense of other stimuli, is mediated bottom‐up by the ascending reticular activating system and top‐down by the prefrontal, parietal and limbic cortices (<a href="./references#CD009221-bbs2-0013" title="Aharon‐PeretzJ , TomerR . Traumatic brain injury. In: BLMiller , JLCummings editor(s). The Human Frontal Lobes: Functions and Disorders. 2nd Edition. New York: The Guilford Press, 2007:540‐51. ">Aharon‐Peretz 2007</a>). Those with TBI demonstrate slowed reaction times, poor sustained attention, difficulty in ignoring task‐irrelevant information and perform poorly on tests of divided attention (<a href="./references#CD009221-bbs2-0013" title="Aharon‐PeretzJ , TomerR . Traumatic brain injury. In: BLMiller , JLCummings editor(s). The Human Frontal Lobes: Functions and Disorders. 2nd Edition. New York: The Guilford Press, 2007:540‐51. ">Aharon‐Peretz 2007</a>). The Central Executive System (CES) component of working memory appears to be particularly vulnerable in TBI, and impairment is associated with other symptoms of the dysexecutive syndrome (<a href="./references#CD009221-bbs2-0039" title="McDowellS , WhyteJ , D'EspositonM . Working memory impairments in traumatic brain injury: evidence from a dual‐task paradigm. Neuropsychologia1997;35(10):1341‐53. ">McDowell 1997</a>). Executive dysfunction may partly explain problems with recall of long‐term episodic and semantic memory, due to an ineffective search strategy, though damage in the medial temporal lobes or diencephalic structures will cause anterograde amnesia that is characterised by impaired recall and recognition. Closed‐head injury tends to cause cognitive impairment in multiple domains whereas penetrating injuries can result in a focal cognitive deficit. </p> <p>The UK's 'National Service Framework for Long Term Conditions' (<a href="./references#CD009221-bbs2-0024" title="Department of Health. The National Service Framework for Long‐term Conditions. www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4105361&amp;chk=jl7dri. ">DH</a>) has highlighted the need for comprehensive interdisciplinary care that improves people's quality of life and carers' distress. Neurocognitive problems following TBI are one of the most important factors in determining people's subjective well‐being and their quality of life (<a href="./references#CD009221-bbs2-0049" title="TeasdaleTW , EngbergAW . Psychosocial consequences of stroke: a long‐term population‐based follow‐up. Brain Injury2005;19(12):1049‐58. ">Teasdale 2005</a>). Hence, the focus is on improving neurocognitive functions, which may include the use of pharmacological approaches in addition to traditional neurorehabilitation. </p> </section> <section id="CD009221-sec-0018"> <h3 class="title" id="CD009221-sec-0018">Description of the intervention</h3> <p>The interventions to be studied are all widely‐available, centrally acting pharmacological agents that affect one or more of the major neurotransmitter systems (dopaminergic, serotonergic, GABAergic, glutamatergic and cholinergic) that are thought to underpin cognitive functions. </p> </section> <section id="CD009221-sec-0019"> <h3 class="title" id="CD009221-sec-0019">How the intervention might work</h3> <p>The neurotransmitter changes caused by traumatic brain injury have been far more extensively researched in the acute phase of brain injury than in chronic TBI (<a href="./references#CD009221-bbs2-0041" title="MysiwW , SandelM . The agitated brain injured patient. Part 2: Pathophysiology and treatment. Archives of Physical Medicine and Rehabilitation1997;78(2):213‐20. ">Mysiw 1997</a>). During the acute phase the location of the injury results in different patterns of altered neurotransmitter function (<a href="./references#CD009221-bbs2-0052" title="VanWoerkomTC , TeelkenAW , MinderhousJM . Difference in neurotransmitter metabolism in frontotemporal‐lobe contusion and diffuse cerebral contusion. Lancet1977;1(8015):812‐3. ">Van Woerkom 1977</a>). However, there are reasons to suspect that pharmacological manipulation of neurotransmitter systems in chronic TBI could enhance cognitive function. </p> <p>Animal neurotransmitter studies have shown dopamine (DA) is found in high concentrations in the dorsolateral prefrontal cortex and anterior cingulate, areas known to be intimately involved in working memory, attention and executive cognitive functioning (<a href="./references#CD009221-bbs2-0043" title="PrevicFH . Dopamine and the origins of human intelligence. Brain and Cognition1999;41(3):299‐350. ">Previc 1999</a>). The noradrenergic (NA) neurones originate in the locus coeruleus and lateral tegmental area and project into the cerebellum and hippocampus as well as diffusely through the cerebral cortex. Both NA and DA are known to play significant roles in arousal, motivation, learning and memory (<a href="./references#CD009221-bbs2-0021" title="CooperJR , BloomFE , Roth RH(editors) . Dopamine. The Biochemical Basis of Neuropharmacology. New York: Oxford University Press, 1991:285‐332. ">Cooper 1991a</a>; <a href="./references#CD009221-bbs2-0022" title="CooperJR , BloomFH , Roth RH(editors) . Norepinephrine and epinephrine. The Biochemical Basis of Neuropharmacology. New York: Oxford University Press, 1991:220‐84. ">Cooper 1991b</a>). </p> <p>Severe TBI (acute Glasgow coma scale (GCS) ≤ 8) with diffuse axonal injury is associated with reduced turnover of 5‐hydroxy tryptophan (5HT). The serotonergic system is implicated in the function of the reticular activating system (RAS) and hippocampus, involved in alertness and memory respectively (<a href="./references#CD009221-bbs2-0053" title="VanWoerkomTC , MinderhoudJM . Pharmacologic interventions. Physical Medicine and Rehabilitation: Review1990;4(3):447‐64. ">Van Woerkom 1990</a>). The serotonergic system, which projects from the midline raphe to the limbic system, neostriatum, thalamus and cerebellar and cerebral cortices, is involved in arousal, memory, mood and learning (<a href="./references#CD009221-bbs2-0023" title="CooperJR , BloomFE , Roth RH(editors) . Serotonin and histamine. The Biochemical Basis of Neuropharmacology. New York: Oxford University Press, 1991:338‐80. ">Cooper 1991c</a>). </p> <p>There are two main cholinergic systems. The basal forebrain cholinergic complex includes the nucleus basalis of Meynert, septal nuclei and the nucleus of the diagonal band. A second system arises from the pedunculopontine and laterodorsal tegmental nuclei and these project to the thalamus, cerebellum and ascending reticular formation. The cholinergic system therefore helps maintain arousal and has been found to increase neuronal responsiveness to sensory input (<a href="./references#CD009221-bbs2-0030" title="HeilmanKM , WatsonRT , ValensteinE . Neglect and related disorders. In: KMHeilman , EValenstein editor(s). Clinical Neuropsychology. New York: Oxford University Press, 1993:279‐336. ">Heilman 1993</a>). An increase in cholinergic function is necessary for tasks requiring sustained and divided attention, maintaining vigilance, neural plasticity required for laying down memory and recognition memory (<a href="./references#CD009221-bbs2-0050" title="TenovuoOS . Cholinergic treatment of traumatic brain injury. Current Drug Therapy2006;1(2):187‐209. ">Tenovuo 2006</a>). It has been suggested that following TBI there is a perturbation of cholinergic systems (<a href="./references#CD009221-bbs2-0029" title="HayesRL , LyethBG , JenkinsLW . Neurochemical mechanisms of mild and moderate head injury: implications for treatment. In: LevinHS , EisenbergHM , BentonAL editor(s). Mild Head Injury. New York: Oxford University Press, 1989. ">Hayes 1989</a>). After an acute period of increased cholinergic activity, a long‐standing hypocholinergic state develops. Structures in the medial temporal lobes, such as the hippocampus and limbic system that are rich in cholinergic neurons, are highly susceptible to traumatic and hypoxic injury (<a href="./references#CD009221-bbs2-0014" title="ArciniegasD , AdlerL , TopkoffJ , CawthraE , FilleyCM , ReiteM . Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Injury1999;13(1):1‐13. ">Arciniegas 1999</a>). </p> </section> <section id="CD009221-sec-0020"> <h3 class="title" id="CD009221-sec-0020">Why it is important to do this review</h3> <p>Whilst Poole and Agrawal examined the role for cholinergic agents in TBI (<a href="./references#CD009221-bbs2-0057" title="PooleNA , AgrawalN . Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review. Brain Injury2008;22(7):519‐34. ">Poole 2008</a>), there has not yet been a systematic review or meta‐analysis of all commonly used psychotropic drugs in chronic cognitive impairment. Given the lack of knowledge of chronic changes in neurotransmitter systems following TBI the authors believed that it was sensible to study all psychotropic drugs that modulate the main neurotransmitter systems (noradrenaline, dopamine, serotonin, glutamate, acetylcholine). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009221-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009221-sec-0021"></div> <p>To assess the effects of centrally acting pharmacological agents for treatment of chronic cognitive impairment subsequent to traumatic brain injury in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009221-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009221-sec-0022"></div> <section id="CD009221-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009221-sec-0024"> <h4 class="title">Types of studies</h4> <p>As outlined in the protocol (<a href="./references#CD009221-bbs2-0042" title="PooleN , DougallD , AgrawalN . Pharmacotherapy for chronic cognitive impairment in traumatic brain injury. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD009221] ">Poole 2011</a>), we only included randomised controlled trials (RCTs) or cross‐over design studies assessing the effectiveness of any one centrally acting pharmacological agent that affects one or more of the main neurotransmitter systems in people with chronic traumatic brain injury (12 months or longer since the injury). We chose twelve months as a suitable time point because the majority of spontaneous biological improvement in neurocognitive functions takes place within this period (<a href="./references#CD009221-bbs2-0016" title="BrooksDN . Wechsler Memory Scale performance and its relationship to brain damage after severe closed head injury. Journal of Neurology, Neurosurgery and Psychiatry1976;39(6):593‐601. ">Brooks 1976</a>); and only a few people show significant spontaneous recovery after 12 months (<a href="./references#CD009221-bbs2-0033" title="JennettB , BondM . Assessment of outcome after severe brain damage: a practical scale. Lancet1975;305(7905):480‐4. ">Jennett &amp; Bond 1975</a>). However, we acknowledge that any chosen time point is somewhat arbitrary. We only included trials if treatment with the pharmacological agent was compared with a placebo control group, and required that included trials showed evidence of concealment of allocation to treatment and control groups. </p> </section> <section id="CD009221-sec-0025"> <h4 class="title">Types of participants</h4> <p>Human adults who have sustained mild to severe traumatic brain injury (TBI) resulting in chronic cognitive impairment. </p> </section> <section id="CD009221-sec-0026"> <h4 class="title">Types of interventions</h4> <p>1) Antidepressants</p> <p>2) Antipsychotics</p> <p>3) Dopamine agonists</p> <p>4) Cholinergic agents</p> <p>5) Psychostimulants</p> <p>The authors reviewed trials investigating all centrally acting pharmacological agents that modulate the main neurotransmitter systems. </p> <p>We did not review combinations of pharmacological agents because pharmacodynamic and kinetic factors would obscure the results. </p> <p>We required that the intervention must be instigated 12 months or more after the injury.</p> </section> <section id="CD009221-sec-0027"> <h4 class="title">Types of outcome measures</h4> <p>We required all outcome measures to be valid measures of the domain in question (that is tests of memory must be validated as such). However, we expected a wide variety of measures to be employed across studies and so we did not require that each one has been validated in the TBI population as this was anticipated to limit the number of studies that could be included. We required outcome measures to have demonstrated a high test‐retest reliability (&gt; 0.8) in studies assessing their psychometric properties. </p> <section id="CD009221-sec-0028"> <h5 class="title">Primary outcomes</h5> <p>• Global severity of cognitive impairment</p> <p>• Memory performance on psychometric tests</p> <p>• Performance on neuropsychological tests that evaluate other aspects of cognitive functioning </p> <p>• Scores on screening measures assessing cognitive function or general severity of cognitive impairment (e.g. mini–mental state examination (MMSE), Cambridge cognitive assessment (CAMCOG), Alzheimer disease assessment scale‐cognitive (ADAS‐Cog) or clinical dementia rating (CDR) scale </p> <p>• Clinical global impression of change</p> </section> <section id="CD009221-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p>• Acceptability of treatment (as measured by withdrawal from trial)</p> <p>• Safety (as measured by incidence of adverse effects)</p> <p>• Mortality</p> <p>• Subjective benefit (as measured by a validated tool)</p> </section> </section> </section> <section id="CD009221-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009221-sec-0031"> <h4 class="title">Electronic searches</h4> <p>We searched ALOIS (<a href="http://www.medicine.ox.ac.uk/alois" target="_blank">www.medicine.ox.ac.uk/alois</a>)—the Cochrane Dementia and Cognitive Improvement Group’s Specialised Register—on 16 November 2011, 23 February 2013, 20 January 2014 and 30 December 2014. The search terms used were: traumatic OR TBI OR "brain injury" OR "brain injuries" OR TBIs OR "axonal injury" OR "axonal injuries". </p> <p>ALOIS is maintained by the Trials Search Co‐ordinator of the Cochrane Dementia and Cognitive Improvement Group and contains studies in the areas of dementia prevention, dementia treatment and cognitive enhancement in healthy people. The studies are identified from:   </p> <p> <ol id="CD009221-list-0001"> <li> <p>Monthly searches of a number of major healthcare databases: MEDLINE (Ovid SP), EMBASE (Ovid SP), CINAHL, (EBSCOhost), PsycINFO (Ovid SP) and LILACS (BIREME) </p> </li> <li> <p>Monthly searches of a number of trial registers: ISRCTN; UMIN (Japan's Trial Register); the WHO portal (which covers ClinicalTrials.gov; ISRCTN; the Chinese Clinical Trials Register; the German Clinical Trials Register; the Iranian Registry of Clinical Trials; and the Netherlands National Trials Register; plus others) </p> </li> <li> <p>Quarterly search of <i>The Cochrane Library</i>’s Central Register of Controlled Trials (CENTRAL) </p> </li> <li> <p>Six‐monthly searches of a number of grey literature sources: ISI Web of Knowledge Conference Proceedings; Index to Theses; Australasian Digital Theses </p> </li> </ol> </p> <p>To view a list of all sources searched for ALOIS see <a href="http://www.medicine.ox.ac.uk/alois/content/about-alois" target="_blank">About ALOIS</a> on the ALOIS website. </p> <p>Details of the search strategies used for the retrieval of reports of trials from the healthcare databases, CENTRAL and conference proceedings can be viewed in the ‘Methods used in reviews’ section within the editorial information about the <a href="http://mrw.interscience.wiley.com/cochrane/clabout/articles/DEMENTIA/frame.html" target="_blank">Dementia and Cognitive Improvement Group</a>. </p> <p>We performed additional searches in many of the sources listed above to cover the timeframe from the last searches performed for ALOIS to ensure that the search for the review was as up to date and as comprehensive as possible. The search strategies used can be seen in <a href="./appendices#CD009221-sec-0069">Appendix 1</a>. </p> <p>The searches retrieved a total of 9200 results. After a first‐assess and a de‐duplication, 676 references were left to further assess for possible inclusion or exclusion within the review. </p> </section> <section id="CD009221-sec-0032"> <h4 class="title">Searching other resources</h4> <p>The authors handsearched the bibliographies of all relevant papers identified for any additional citations and also consulted experts and pharmaceutical companies to check for any omissions from our identified studies. </p> </section> </section> <section id="CD009221-sec-0033"> <h3 class="title" id="CD009221-sec-0033">Data collection and analysis</h3> <section id="CD009221-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Two authors (DD and NP) examined titles and abstracts of citations obtained from the search, and obviously irrelevant articles were discarded. An article was retrieved for further assessment in the presence of any suggestion that the article described a relevant randomised controlled trial. </p> <p>Two authors (DD and NP) independently assessed the retrieved articles for inclusion in the review according to the criteria above. Disagreements were resolved by discussion. </p> </section> <section id="CD009221-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Two authors (DD and NP) extracted data. If any differences emerged then agreement was reached by consensus.<br/> <br/> The authors extracted data from the published reports using standardised tools. In addition to summary statistics for each trial and each outcome we extracted details on the number and types of participants, the interventions, randomisation and blinding. For continuous data we extracted the mean change from baseline, the standard error of the mean change, and the number of participants for each treatment group at each assessment. For binary data we sought the numbers in each treatment group and the numbers experiencing the outcome of interest. We requested additional data from the original study authors if this data was unavailable in the published paper. </p> <p>We defined the baseline assessment as the latest available assessment prior to randomisation, but no longer than two months before. </p> <p>We sought data for each outcome measure and on every person assessed.</p> <p>In studies where a cross‐over design was used, we only extracted data from the first treatment phase after randomisation. </p> </section> <section id="CD009221-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The same review author (DD) assessed the methodological quality of all studies included in the review. The author used the Cochrane 'Risk of bias' tool as described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009221-bbs2-0031" title="HigginsJPT , GreenS (Editors) . Cochrane Handbook for Systematic Reviews and Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), to assess the methods used by each study to control six potential sources of bias (sequence generation; allocation concealment; blinding of participants, personnel and outcome assessors; incomplete outcome data; selective outcome reporting; and other sources of bias). Overall quality of evidence was assessed using the GRADE approach (<a href="./references#CD009221-bbs2-0046" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editors. GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.6 [updated October 2011]. The GRADE Working Group2011. ">Schünemann 2011</a>). </p> <p>The authors gave particular emphasis to allocation concealment, as empirical research has shown that a lack of adequate allocation concealment is associated with bias. Trials with unclear concealment measures have been shown to yield more pronounced estimates of treatment effects than trials that have taken adequate measures to conceal allocation schedules, but this is less pronounced than for inadequately concealed trials (<a href="./references#CD009221-bbs2-0020" title="ChalmersTC , CelanoP , SacksHS , SmithHJr . Bias in treatment assignment in controlled clinical trials. New England Journal of Medicine1983;309(22):1358‐61. ">Chalmers 1983</a>; <a href="./references#CD009221-bbs2-0045" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association1995;273(5):408‐12. ">Schulz 1995</a>). Thus trials were included if they were of low or unclear risk, whilst those assessed as high risk were not. </p> </section> <section id="CD009221-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>The authors expressed the treatment effect for continuous outcomes, as the mean difference. For dichotomous outcomes, we expressed risk ratios which for clinicians are easier to interpret than odds ratios. We did not report treatment effects in terms of number needed to treat for an additional beneficial outcome (NNTB) as the data extracted gave mean changes from baseline only and could not be interpreted in terms of treatment response. </p> </section> <section id="CD009221-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>The authors only included data from the first treatment phase after randomisation in studies of a cross‐over design. </p> </section> <section id="CD009221-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>The authors sought intention‐to‐treat data but, if unavailable in the publications, we included 'on‐treatment' data or the data for those who completed the trial. </p> </section> <section id="CD009221-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>The authors did not conduct an assessment of heterogeneity as the three studies identified were clinically heterogeneous and results were not pooled. </p> </section> <section id="CD009221-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>The authors minimised the potential for publication bias by contacting study authors, pharmaceutical companies and experts to assist in the identification of unpublished studies. Furthermore, we contacted authors of identified studies to enquire about duplication of studies and outcome reporting bias. </p> <p>We did not create a funnel plot as an insufficient number of studies were identified.</p> </section> <section id="CD009221-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We deemed data synthesis to be inappropriate due to the small number of studies identified, which also differed in interventions and outcome measures. </p> </section> <section id="CD009221-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not assess for statistical heterogeneity as data synthesis was not possible.</p> </section> <section id="CD009221-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>We did not conduct sensitivity analyses as we did not conduct data synthesis.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009221-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009221-sec-0045"></div> <section id="CD009221-sec-0046"> <h3 class="title">Description of studies</h3> <section id="CD009221-sec-0047"> <h4 class="title">Results of the search</h4> <p>The results of the search are summarised in <a href="#CD009221-fig-0001">Figure 1</a>. A total of 9200 records were identified after removal of duplicates and first assessment. One additional paper was identified after contacting a study author (<a href="./references#CD009221-bbs2-0005" title="JohanssonB , WentzelA‐P , AndréllP , MannheimerC , RönnbäckL . Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury. Brain Injury2015;29(6):758‐65. ">Johansson 2015</a>). A total of 676 papers were reviewed for suitability for inclusion, of which four studies met the criteria for inclusion. Two cross‐over studies could not be included as they did not report separate phase one outcome data, which the authors were unable to provide when contacted (<a href="./references#CD009221-bbs2-0009" title="SpeechTJ , RaoSM , OsmonDC , SperryLT . A double‐blind controlled study of methylphenidate treatment in closed head injury. Brain Injury1993;7(4):333‐8. ">Speech 1993</a>; <a href="./references#CD009221-bbs2-0010" title="TenovuoO , AlinJ , HeleniusH . A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury—What it showed and taught?. Brain Injury2009;22(6):548‐58. ">Tenovuo 2009</a>). One study did not include a placebo control group (<a href="./references#CD009221-bbs2-0005" title="JohanssonB , WentzelA‐P , AndréllP , MannheimerC , RönnbäckL . Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury. Brain Injury2015;29(6):758‐65. ">Johansson 2015</a>). One study investigating rivastigmine was identified to be ongoing, and is described in the <a href="./references#CD009221-sec-0081" title="">Characteristics of ongoing studies</a> table. </p> <div class="figure" id="CD009221-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009221-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD009221-sec-0048"> <h4 class="title">Included studies</h4> <p>The four studies meeting inclusion criteria are described in the <a href="./references#CD009221-sec-0079" title="">Characteristics of included studies</a> tables. One study investigated modafinil (<a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a>), a wake‐promoting agent with effects on multiple neurotransmitter systems, including histaminergic, serotonergic, and glutaminergic activity that may be secondary to stimulation of catecholamine systems (<a href="./references#CD009221-bbs2-0040" title="MinzenbergMJ , CarterCS . Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology2008;33(7):1477‐502. ">Minzenberg 2008</a>). The second investigated (−)‐OSU6162 (<a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a>), a monoamine stabiliser agent with dopaminergic (<a href="./references#CD009221-bbs2-0036" title='LathiR , TammingaCA , CarlssonA . Stimulating and inhibitory effects of the dopamine "stabiliser" (‐)‐OSU6162 on dopamine D(2) receptor function in vitro. Journal of Neural Transmission2007;114(9):1143‐46. '>Lahti 2007</a>), and serotonergic effects (<a href="./references#CD009221-bbs2-0018" title="BursteinES , CarlssonML , OwensM , MaJ‐N , SchifferHH , CarlssonA , et al. In vitro evidence that (‐)‐OSU6162 and (+)‐OSU6162 produce their behavioural effects through 5‐HT2A serotonin and D2 dopamine receptors. Journal of Neural Transmission2011;118(11):1523‐33. ">Burstein 2011</a>; <a href="./references#CD009221-bbs2-0019" title="CarlssonML , BursteinES , KlobergA , HanssonS , SchedwinA , NilssonM , et al. In vivo evidence for partial agonist effects of (‐)‐OSU6162 and (+)‐OSU6162 on 5‐HT2A serotonin receptors. Journal of Neural Transmission2011;118(11):1511‐22. ">Carlsson 2011</a>). The third investigated atomoxetine (<a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a>), a noradrenaline reuptake inhibitor (<a href="./references#CD009221-bbs2-0056" title="ZerbeRL , RoweH , EnasGG , WongD , FaridN , LembergerL . Clinical pharmacology of tomoxetine, a potential antidepressant. Journal of Pharmacology and Experimental Therapeutics1985;232(1):139‐43. ">Zerbe 1985</a>). Lastly, <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> investigated rivastigmine which is an acetylcholinesterase and butyrylcholinesterase inhibitor (<a href="./references#CD009221-bbs2-0027" title="GiacobiniE , SpiegelR , EnzA , VeroffAE , CutlerNR . Inhibition of acetyl‐ and butyryl‐cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit. Journal of Neural Transmission2002;109(7‐8):1053‐65. ">Giacobini 2002</a>). Three studies (<a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a>, <a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> and <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a>) were conducted in the United States, whilst <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a> was conducted in Sweden. </p> <p><a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a> is a single centre randomised placebo‐controlled crossover trial, examining the efficacy of modafinil in the treatment of fatigue or excessive day‐time sleepiness, which included secondary measures assessing global and cognitive function. Fifty‐one men and women aged 16 to 65 were recruited from an inpatient rehabilitation unit. For inclusion, participants were required to suffer from fatigue or excessive daytime sleepiness that compromised functioning. Although the mean baseline ImPACT (Immediate Post Concussion Assessment Cognitive Testing) score was provided for the group this is difficult to interpret. The ImPACT is a neuropsychological test which compares the subject against aged‐matched normative data. It would therefore be important to know the baseline for each individual to ascertain the degree of cognitive impairment at baseline. Relevant exclusion criteria were: the presence of a neurological or neuropsychiatric diagnosis that would impair evaluation of the intervention; other diagnoses that may cause excessive daytime sleepiness; concurrent medication use; clinically significant systemic medical conditions; epilepsy; cardiovascular disease; severe hepatic or renal impairment; psychiatric or behavioural disturbance that would impair evaluation of the intervention; pregnancy. In the treatment arm, modafinil was titrated to 200 mg twice daily orally over a two‐week period and continued for a further eight weeks. Participants in the placebo arm were administered tablets at the same frequency as for modafinil. After a four‐week washout period participants were switched to the opposite arm. The primary outcome measures of the study related to fatigue and daytime sleepiness. Relevant cognitive or global outcome measures included the Medical Outcome Study 12‐Item Short Form Survey (SF‐12), ImPACT, and the Conners' Continuous Performance Test II (CPT‐II). The measures were administered at baseline, week four and week ten of treatment (repeated at week four and ten following cross‐over). Only results from the first treatment phase were included in this review. We contacted the study authors who provided unpublished phase one outcome data for cognitive outcomes and adverse effects. </p> <p><a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a> is a single centre cross‐over randomised placebo controlled study, examining the efficacy of (−)‐OSU6162 on long‐term mental fatigue following TBI or stroke. Twelve men and women aged 30 to 65 were recruited through a local Swedish newspaper advertisement or from the Department of Neurology at Sahlgrenska University Hospital in Gothenburg. Participants were included if they were at least one year post‐TBI or stroke, but not more than 10 years, and had suffered pathological mental fatigue for at least one year. Participants were required to have otherwise recovered from neurological symptoms, have a Glasgow Outcome Scale (Extended) (GOS‐E) score indicating at least moderate disability or better (&gt; 5), and have completed education to high school equivalent and speak Swedish. Participants were excluded if they were deemed to suffer significant cognitive impairment, as measured by scores more than two standard deviations worse on the cognitive tests used by the study, or in the case of significant neurological or psychiatric comorbidity, substance misuse, or pregnancy. Participants receiving (−)‐OSU6162 were administered 15 mg twice daily in week one, 30 mg twice daily in week two, and 45 mg twice daily in weeks three and four. Dose variation was possible if a participant had responded at a lower dose and then experienced decreased efficacy or adverse effects at a higher dose, therefore permitting a reduction to the previous dose. The process of administration in the placebo arm was not explicitly described. The primary outcome measure of the study assessed fatigue. The relevant secondary cognitive outcome measures were the Trail Making Tests A,B,C &amp; D, WAIS‐III digit symbol coding, WAIS‐III digit span and the FAS verbal fluency test. These were administered at baseline and four weeks. A week 8 assessment was conducted following the crossover, the results of which are not relevant to this review. We contacted the study authors, who provided unpublished outcome data specific to TBI participants in phase one of the trial. </p> <p><a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> is a single centre randomised placebo‐controlled cross‐over trial, examining the efficacy of atomoxetine in the treatment of attention impairment. Sixty men and women aged 18 to 65 were recruited by posting flyers to people who had received inpatient rehabilitation following TBI, or through clinicians handing leaflets to people with TBI in the community. Flyers were also distributed to various brain injury organisations. For inclusion, participants were required to have a history of moderate to severe TBI, defined by a Glasgow Coma Scale score of 12 or less, post‐traumatic amnesia which lasted more than 24 hours or radiographic evidence of intracranial trauma. Telephone screening was conducted to administer the Adult ADHD Self‐Report Scale (ASRS‐v1.1) and the Cognitive Failures Questionnaire (CFQ). The Other CFQ was also administered if a primary carer or significant other was available. A score of four or higher on the ASRS, 0.35 or higher on the CFQ, or 0.42 or higher on the Other CFQ was required for inclusion. Exclusion criteria were: non‐English speaking participants; current seizure history; cardiovascular disease; history of psychiatric illness requiring hospital treatment; use of monoamine oxidase inhibitors; severe renal or hepatic impairment; pregnancy or lactating. After baseline assessment all participants received a placebo run‐in for two weeks. In the treatment arm, atomoxetine 40 mg was administered twice a day for two weeks. Participants in the placebo arm were administered tablets of identical appearance according to the same schedule. After a two‐week placebo washout period participants were switched to the opposite arm for a further two weeks. The primary outcome measure of the study was the Power of Attention factor of the Cognitive Drug Research (CDR) Computerized Cognitive Assessment System. The CDR is a computer‐controlled battery of tests that provides factor scores for Power of Attention (POA), Continuity of Attention (COA), Quality of Working Memory (QWM), Quality of Episodic Memory (QEM), and Speed of Memory (SOM). Secondary measures in the study included COA, QEM and SOM factor scores of the CDR. Further secondary measures were the Efficiency of Attention score calculated from the Power of Attention score, Stroop Colour and Word Test, the Adult ADHD Self‐Report Scale and Neurobehavioral Functioning Inventory scores. Only results from the first treatment phase were included in this review. The study authors provided unpublished phase one outcome data for cognitive outcomes and adverse effects on request. </p> <p><a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> is a multicentre randomised placebo controlled trial examining the efficacy of rivastigmine on cognitive function. One‐hundred and fifty men and women aged 18 to 50 were recruited across 19 sites. Participants with cognitive impairment following non‐penetrating traumatic brain injury were included. At baseline, participants were required to have a difference of at least one standard deviation between current estimated intelligence measured by the Wechsler Adult Intelligence Scale, third edition (WAIS‐III) and current verbal attention or verbal memory functioning measured by the Cambridge Neuropsychological Test Automated Battery Rapid Visual Information Processing A subtest (CANTAB RVIP A) or the Hopkins Verbal Learning Test (HVLT) total trials one to three. Relevant exclusion criteria were: medical, psychiatric or substance use disorders that could impair evaluation of the intervention; acute or severe pulmonary or cardiovascular disease; primary neurodegenerative disorders; epilepsy; medication known to affect cognitive functioning in TBI; history of major brain surgery or penetrating brain injury. Participants receiving rivastigmine started at 1.5 mg twice daily for four weeks, after which the dose was increased to 3 mg twice daily. If not tolerated due to adverse side effects, the dose could either be reduced to 4.5 mg or 3 mg daily (also in divided doses). A matching placebo was administered according to the same schedule as for rivastigmine. Primary outcome measures were the CANTAB RVIP A and the HVLT. These were administered at baseline and weeks four, eight and twelve. Secondary outcome measures were only administered at baseline and week twelve, and included; Controlled Oral Word Association; WAIS‐III Digit span; WAIS‐III Letter Number Sequencing; and Trail Making Tests Parts A and B. We contacted the study authors for additional data, which was unavailable. Therefore, outcomes for the Neurobehavioral Functioning Inventory (NFI), Diener Satisfaction with Life Scale, and Clinical Global Impression of Change (CGI) could not be reported. </p> </section> <section id="CD009221-sec-0049"> <h4 class="title">Excluded studies</h4> <p>We excluded two cross‐over studies as neither reported phase 1 outcome data, which the authors were unable to provide when contacted (<a href="./references#CD009221-bbs2-0009" title="SpeechTJ , RaoSM , OsmonDC , SperryLT . A double‐blind controlled study of methylphenidate treatment in closed head injury. Brain Injury1993;7(4):333‐8. ">Speech 1993</a>; <a href="./references#CD009221-bbs2-0010" title="TenovuoO , AlinJ , HeleniusH . A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury—What it showed and taught?. Brain Injury2009;22(6):548‐58. ">Tenovuo 2009</a>). We excluded three other studies as the time since TBI was not clearly stated (<a href="./references#CD009221-bbs2-0006" title="León‐CarriónJ , Dominguez‐RoldánJM , Murillo‐CabezasF , delRosario Dominguez‐MoralesM , Muñoz‐SanchezMA . The role of citicholine in neuropsychological training after traumatic brain injury. NeuroRehabilitation2000;14(1):33‐40. ">León‐Carrión 2000</a>; <a href="./references#CD009221-bbs2-0007" title="PlengerPM , DixonCE , CastilloRM , FrankowskiRF , YablonSA , LevinHS . Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double‐blind placebo‐controlled study. Archives of Physical Medicine and Rehabilitation1996;77(6):536‐40. ">Plenger 1996</a>; <a href="./references#CD009221-bbs2-0008" title="SchneiderWN , Drew‐CatesJ , WongTM , DombovyML . Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double‐blind placebo‐controlled study. Brain Injury1999;13(11):863‐72. ">Schneider 1999</a>). One study (<a href="./references#CD009221-bbs2-0005" title="JohanssonB , WentzelA‐P , AndréllP , MannheimerC , RönnbäckL . Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury. Brain Injury2015;29(6):758‐65. ">Johansson 2015</a>) was excluded as the control group did not receive a placebo. </p> </section> </section> <section id="CD009221-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>Judgements for risks of bias are detailed in the <a href="./references#CD009221-sec-0079" title="">Characteristics of included studies</a> section and summarised in <a href="#CD009221-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD009221-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009221-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD009221-sec-0051"> <h4 class="title">Allocation</h4> <p><a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a> and <a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> described adequate procedures to reduce selection bias and were rated as low risk. <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a> did not describe the randomisation process, other than reporting that an external system was employed; therefore we rated the study as unclear risk for random sequence generation, and low risk of allocation concealment due to the use of an external process. A limited description of the randomisation and concealment process was provided by <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a>; therefore we rated the risks of bias as unclear. </p> </section> <section id="CD009221-sec-0052"> <h4 class="title">Blinding</h4> <p>All studies were assessed to be of low risk of bias.</p> </section> <section id="CD009221-sec-0053"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed risk of attrition bias as high in <a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a> as not all participants who were randomised were included in the analysis and reference was not made to intention‐to‐treat analysis. We assessed <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a>, <a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> and <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> as low risk. </p> </section> <section id="CD009221-sec-0054"> <h4 class="title">Selective reporting</h4> <p>Outcomes were reported as planned in the protocol by <a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a>, <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a>, and <a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> , and therefore we assessed reporting bias as low risk. </p> <p><a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> varied from the protocol in terms of inclusion criteria and outcome measurement time‐scales. The published protocol registered with ClinicalTrials.gov planned to include participants aged 18 to 65, while the published study states the inclusion criteria as 18 to 50 years. Of more concern, a different cognitive battery was used in the study to that proposed in the protocol to determine inclusion into the trial. The protocol included subjects one standard deviation or more below the mean on the California Verbal Learning test, Tower of London test, Verbal Memory Learning test and the Test Battery for Attentional Performance. However, the completed study included subjects who performed below one standard deviation on the Verbal subtest on the Wechsler Adult Intelligence Scale (WAIS) and attention or verbal memory as assessed by the Cambridge Neuropsychological Test Automated Battery CANTAB), Rapid Visual Information processing (RVIP), or the Hopkins Verbal learning Test (HVLT). Also, the protocol planned for treatment for 20 weeks, as opposed to 12 weeks in the completed study. Both these discrepancies appear to have been balanced across both arms of the study: we therefore assessed the risk of bias as low. </p> </section> <section id="CD009221-sec-0055"> <h4 class="title">Other potential sources of bias</h4> <p>Only <a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> and <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> investigated treatment of cognitive impairment as a primary outcome measure, with <a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a> and <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a> primarily investigating treatment of fatigue. Limited information on the severity of TBI was provided by the studies, and similarly limited data on baseline cognitive impairment at inclusion were provided. These factors may have introduced bias through variation in the recruitment or selection of participants, and consequently assessment of outcome. </p> </section> </section> <section id="CD009221-sec-0056"> <h3 class="title" id="CD009221-sec-0056">Effects of interventions</h3> <p>See: <a href="./full#CD009221-tbl-0001"><b>Summary of findings for the main comparison</b> Pharmacological agents compared to placebo for chronic cognitive impairment in traumatic brain injury</a> </p> <p>Each of the reported studies included measures relating to one of the primary outcomes of this review: namely, cognitive function as assessed by standardised psychometric tests. Of the four studies, only <a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> and <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> reported cognitive function as a primary outcome measures. Primary outcome measures for <a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a> were for fatigue; and for <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a>, mental fatigue. Reported secondary measures included safety and acceptability data. Due to the small numbers, we have reported outcomes separately for each study. Synthesis of data was not possible, with sub‐tests of psychometric batteries favouring both treatment and placebo arms, as shown in <a href="./full#CD009221-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>In <a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a> unpublished data for relevant cognitive outcomes were provided by the study authors. These data were generated by the Statistical Package for the Social Sciences (SPSS), rather than the original statistician’s Statistical Analysis Software (SAS) syntax for the mixed model used in the published paper. Consequently this resulted in different mean scores compared to the original study, but not to the significance of the findings. A single significant difference at week 4 was found in ImPACT visual motor speed composite score, which was not attributable treatment, as there was a positive change in the placebo arm, whilst the score in the modafinil arm remained essentially unchanged (<a href="./references#CD009221-fig-0007" title="">Analysis 1.5</a>). At week 10, no significant differences between modafinil and placebo were found on all relevant measures, including the SF‐12 mental, SF‐12 physical, ImPACT verbal memory composite, ImPACT visual memory composite, ImPACT visual motor speed composite, ImPACT reaction time composite, CCPT‐II number of omissions or CCPT‐II number of commissions (<a href="./references#CD009221-fig-0011" title="">Analysis 2.1</a> to <a href="./references#CD009221-fig-0018" title="">Analysis 2.8</a>). </p> <p>The Modafinil group experienced more adverse events than those taking placebo. However, there were no significant differences in the effect estimates (<a href="./references#CD009221-fig-0047" title="">Analysis 7.1</a> to <a href="./references#CD009221-fig-0056" title="">Analysis 7.10</a>). Two participants in the treatment arm left the trial early versus none in the control group. Again, this was not statistically significant (<a href="./references#CD009221-fig-0043" title="">Analysis 6.1</a>). No deaths were reported during the study. </p> <p>In <a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> atomoxetine was found not to be significantly different from placebo on all cognitive test (<a href="./references#CD009221-fig-0026" title="">Analysis 4.1</a> to <a href="./references#CD009221-fig-0030" title="">Analysis 4.5</a>). There was no difference in acceptability, with no drop outs reported during the first treatment phase (<a href="./references#CD009221-fig-0046" title="">Analysis 6.4</a>). Numerically more side effects were reported with atomoxetine, but there were no significant differences in effects estimates (<a href="./references#CD009221-fig-0058" title="">Analysis 9.1</a> to <a href="./references#CD009221-fig-0067" title="">Analysis 9.10</a>). These analyses accord with the findings of the original paper (<a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a>), in which no statistical difference between atomoxetine and placebo was found, when pre‐ and post cross‐over phases were combined in the analysis. </p> <p>In <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> rivastigmine was found not to be significantly different from placebo on all cognitive tests (<a href="./references#CD009221-fig-0031" title="">Analysis 5.1</a> to <a href="./references#CD009221-fig-0035" title="">Analysis 5.5</a>, and <a href="./references#CD009221-fig-0037" title="">Analysis 5.7</a> to <a href="./references#CD009221-fig-0042" title="">Analysis 5.12</a>) apart from an effect estimate favouring rivastigmine according to the CANTAB RVIP, mean latency (−44.54 milliseconds, 95% CI −88.62 to −0.46 <a href="./references#CD009221-fig-0036" title="">Analysis 5.6</a>). However, <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> did not report a significant difference for this measure (P = 0.129), which may be explained by the use of a different statistical test. On a secondary analysis of a subgroup of participants with greater cognitive impairment at baseline, as measured by at least 25% impairment on the HVLT, significant superiority of rivastigmine over placebo was found on the CANTAB RVIP mean latency test at weeks four and 12 (reported by the study in graphical format only). Numerical data other than a P value of &lt; 0.05 were not reported, and were not available when requested from the study authors. </p> <p>Placebo was numerically slightly less acceptable than rivastigmine (<a href="./references#CD009221-fig-0044" title="">Analysis 6.2</a>). Rivastigmine was numerically less safe than placebo as measured by adverse effects, with a higher rate of nausea in participants given rivastigmine the only significant difference compared to placebo (19/80, 23.8% versus 6/77, 7.8%, risk ratio 3.05, 95% CI 1.29 to 7.22 <a href="./references#CD009221-fig-0073" title="">Analysis 10.6</a>). No deaths were reported during the study. </p> <p>In <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a> data for phase 1 TBI participants were provided by the study authors. Effect estimates showed significantly higher scores for (−)‐OSU6162 than placebo for Trail Making Test A (−9.20 seconds, 95% CI −12.19 to −6.21 <a href="./references#CD009221-fig-0019" title="">Analysis 3.1</a>), Trail Making Test B (−6.20 seconds, 95% CI, −7.81 to −4.59 <a href="./references#CD009221-fig-0020" title="">Analysis 3.2</a>) and WAIS‐III Digit symbol coding (8.60, 95% CI 6.47 to 10.73 <a href="./references#CD009221-fig-0023" title="">Analysis 3.5</a>) showed significantly higher scores for (−)‐OSU6162 than placebo. Trail Making Test D strongly favoured placebo (53.80 seconds, 95% CI 36.76 to 70.24 <a href="./references#CD009221-fig-0022" title="">Analysis 3.4</a>). No significant differences in effect estimates were found for Trail Making Test C, WAIS‐III digit span, and FAS verbal fluency (<a href="./references#CD009221-fig-0021" title="">Analysis 3.3</a>, <a href="./references#CD009221-fig-0024" title="">Analysis 3.6</a> &amp; <a href="./references#CD009221-fig-0025" title="">Analysis 3.7</a>). One participant required a dose reduction due to adverse effects in the placebo arm. There were no drop‐outs (TBI participants). No reference was made to deaths. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009221-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009221-sec-0057"></div> <section id="CD009221-sec-0058"> <h3 class="title" id="CD009221-sec-0058">Summary of main results</h3> <p>The search has found only seven RCTs (including six cross‐over trials) investigating the pharmacological treatment of chronic cognitive impairment at least 12 months after TBI, with five trials providing data suitable for inclusion. Two cross‐over trials that otherwise met criteria for inclusion were not included as phase one outcome data were unavailable. One trial was rejected as it did not include a placebo control group. </p> <p>The pharmacological agents investigated were modafinil, rivastigmine, atomoxetine, and (−)‐OSU6162. Superiority over placebo for (−)‐OSU6162 was demonstrated in Trail Making Tests A, B and WAIS‐III digit symbol coding, but (−)‐OSU6162 was also inferior to placebo in Trail Making Test D (<a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a>). Superiority over placebo was not demonstrated for modafinil (<a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a>); or atomoxetine (<a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a>). Superiority of rivastigmine over placebo was demonstrated by only one primary measure (CANTAB RVIP, mean latency) according to the effect estimate by this review. Interpretation of this finding is cautioned as <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> did not report a statistically significant difference, which may be attributed to a different statistical test used. In addition the confidence interval for the effect estimate is wide and approaches statistical non‐significance. Separately on a secondary analysis of a subgroup of participants assessed to have greater cognitive impairment, significant superiority of rivastigmine was demonstrated on a single measure (<a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a>). </p> </section> <section id="CD009221-sec-0059"> <h3 class="title" id="CD009221-sec-0059">Overall completeness and applicability of evidence</h3> <p>No strong RCT evidence to support the pharmacological treatment of chronic cognitive impairment in TBI has been found by this review. However, when considering the significant disability associated with chronic TBI, pharmacological treatments may still be considered as part of a comprehensive management strategy for chronic cognitive impairment, including non‐pharmacological approaches for which there is reasonable evidence (<a href="./references#CD009221-bbs2-0038" title="LuJ , GaryKW , NeimeierJP , WardJ , LapaneKL . Randomized controlled trials in adult traumatic brain injury. Brain Injury2012;26(13‐14):1523‐48. ">Lu 2012</a>). </p> </section> <section id="CD009221-sec-0060"> <h3 class="title" id="CD009221-sec-0060">Quality of the evidence</h3> <p>Since only four studies investigating different agents with heterogenous outcome measures met the criteria for inclusion, synthesis of outcomes was not possible. Only two studies concerned the treatment of cognitive impairment as a primary measure (<a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014;</a><a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a>), whilst the other two examined the impact on cognitive function as a secondary outcome, with primary outcomes concerned with the treatment of mental fatigue thereby limiting generalisability (<a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a>; <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a>). That <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a> also excluded participants with significant cognitive impairment further limits generalisability. The small study size of <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a>, with only six TBI participants may have increased the risk of erroneous results. This study also assessed a relatively short period of treatment (four weeks). The majority of the data reported in this review for <a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a>, <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a>, and <a href="./references#CD009221-bbs2-0003" title="RipleyDL , MoreyCE , GerberD , Harrison‐FelixC , BrennerLA , PretzCR , et al. Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial. Brain Injury2014;28(12):1514‐22. ">Ripley 2014</a> were also unpublished. Overall the studies were largely assessed to be at low or unclear risk of bias. </p> <p>Using the GRADE approach, we rated the quality of evidence for cognitive performance on psychometric tests, acceptability and safety as very low. Quality was downgraded one level for each rating, due to: serious indirectness, as two of four studies did not investigate cognitive impairment as a primary outcome; serious inconsistency, due to wide variance of point estimates; and serious imprecision, as the total population size was less than 400. Quality of evidence for clinical global improvement was rated as low, downgraded due to serious indirectness, as the relevant study did not investigate cognitive impairment as a primary outcome; and serious imprecision, as the population size was less than 400. </p> </section> <section id="CD009221-sec-0061"> <h3 class="title" id="CD009221-sec-0061">Potential biases in the review process</h3> <p>Strengths of this review are that a comprehensive search strategy was employed, which together with a bibliographic search is likely to have identified all relevant studies. The title and abstract search and review of full‐text papers was conducted independently by two study authors (DD &amp; NP) to reduce inclusion bias. A limitation was that a single‐author assessment of bias was conducted. A weakness of this review is that phase 1 data from two cross‐over studies were not available from the respective authors (<a href="./references#CD009221-bbs2-0009" title="SpeechTJ , RaoSM , OsmonDC , SperryLT . A double‐blind controlled study of methylphenidate treatment in closed head injury. Brain Injury1993;7(4):333‐8. ">Speech 1993;</a><a href="./references#CD009221-bbs2-0010" title="TenovuoO , AlinJ , HeleniusH . A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury—What it showed and taught?. Brain Injury2009;22(6):548‐58. ">Tenovuo 2009</a>), and therefore could not be included, reducing the number of included studies. However, only <a href="./references#CD009221-bbs2-0010" title="TenovuoO , AlinJ , HeleniusH . A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury—What it showed and taught?. Brain Injury2009;22(6):548‐58. ">Tenovuo 2009</a> reported statistically significant results on two measures, which suggests the findings of this review would not have been substantially altered. </p> </section> <section id="CD009221-sec-0062"> <h3 class="title" id="CD009221-sec-0062">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review reflect those of <a href="./references#CD009221-bbs2-0057" title="PooleNA , AgrawalN . Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review. Brain Injury2008;22(7):519‐34. ">Poole 2008</a> which found little high quality evidence for the pharmacological treatment of cognitive impairment in TBI; whilst no definitive evidence was found, the review concluded that there was suggestive evidence for cholinesterase inhibitors and choline. Another earlier review by <a href="./references#CD009221-bbs2-0028" title="GriffinSL , vanReekumR , MasanicC . A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. The Journal of Neuropsychiatry and Clinical Neurosciences2003;15(1):17‐26. ">Griffin 2003</a> concluded that there was only preliminary evidence for further investigation of cholinergic agents. Since <a href="./references#CD009221-bbs2-0057" title="PooleNA , AgrawalN . Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review. Brain Injury2008;22(7):519‐34. ">Poole 2008</a> which reviewed the RCT by <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a>, only one further RCT relevant to this review has been published (<a href="./references#CD009221-bbs2-0001" title="JhaA , WeintraubA , AllshouseA , MoreyC , CusickC , KittelsonJ , et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. Journal of Head Trauma Rehabilitation2008;23(1):52‐63. ">Jha 2008</a>). Methodological differences between this review and that by <a href="./references#CD009221-bbs2-0057" title="PooleNA , AgrawalN . Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review. Brain Injury2008;22(7):519‐34. ">Poole 2008</a> and <a href="./references#CD009221-bbs2-0028" title="GriffinSL , vanReekumR , MasanicC . A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. The Journal of Neuropsychiatry and Clinical Neurosciences2003;15(1):17‐26. ">Griffin 2003</a> is that it is limited to chronic cognitive impairment, but is also broader by including drugs other than cholinergic agents. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009221-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009221-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009221-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Modafinil vs placebo (4 weeks), Outcome 1 SF‐12 Physical." data-id="CD009221-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Modafinil vs placebo (4 weeks), Outcome 1 SF‐12 Physical.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Modafinil vs placebo (4 weeks), Outcome 2 SF‐12 Mental." data-id="CD009221-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Modafinil vs placebo (4 weeks), Outcome 2 SF‐12 Mental.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Modafinil vs placebo (4 weeks), Outcome 3 ImPACT verbal memory composite." data-id="CD009221-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Modafinil vs placebo (4 weeks), Outcome 3 ImPACT verbal memory composite.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Modafinil vs placebo (4 weeks), Outcome 4 ImPACT visual memory composite." data-id="CD009221-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Modafinil vs placebo (4 weeks), Outcome 4 ImPACT visual memory composite.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Modafinil vs placebo (4 weeks), Outcome 5 ImPACT visual motor speed composite." data-id="CD009221-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Modafinil vs placebo (4 weeks), Outcome 5 ImPACT visual motor speed composite.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Modafinil vs placebo (4 weeks), Outcome 6 ImPACT reaction time composite." data-id="CD009221-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Modafinil vs placebo (4 weeks), Outcome 6 ImPACT reaction time composite.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Modafinil vs placebo (4 weeks), Outcome 7 CCPT‐II No. of omissions." data-id="CD009221-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Modafinil vs placebo (4 weeks), Outcome 7 CCPT‐II No. of omissions.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Modafinil vs placebo (4 weeks), Outcome 8 CCPT‐II No. of commissions." data-id="CD009221-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Modafinil vs placebo (4 weeks), Outcome 8 CCPT‐II No. of commissions.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Modafinil vs placebo (10 weeks), Outcome 1 SF‐12 Physical." data-id="CD009221-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Modafinil vs placebo (10 weeks), Outcome 1 SF‐12 Physical.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Modafinil vs placebo (10 weeks), Outcome 2 SF‐12 Mental." data-id="CD009221-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Modafinil vs placebo (10 weeks), Outcome 2 SF‐12 Mental.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Modafinil vs placebo (10 weeks), Outcome 3 ImPACT verbal memory composite." data-id="CD009221-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Modafinil vs placebo (10 weeks), Outcome 3 ImPACT verbal memory composite.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Modafinil vs placebo (10 weeks), Outcome 4 ImPACT visual memory composite." data-id="CD009221-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Modafinil vs placebo (10 weeks), Outcome 4 ImPACT visual memory composite.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Modafinil vs placebo (10 weeks), Outcome 5 ImPACT visual motor speed composite." data-id="CD009221-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Modafinil vs placebo (10 weeks), Outcome 5 ImPACT visual motor speed composite. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Modafinil vs placebo (10 weeks), Outcome 6 ImPACT reaction time composite ." data-id="CD009221-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Modafinil vs placebo (10 weeks), Outcome 6 ImPACT reaction time composite .</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Modafinil vs placebo (10 weeks), Outcome 7 CCPT‐II No. of omissions." data-id="CD009221-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Modafinil vs placebo (10 weeks), Outcome 7 CCPT‐II No. of omissions.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Modafinil vs placebo (10 weeks), Outcome 8 CCPT‐II No. of commissions." data-id="CD009221-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Modafinil vs placebo (10 weeks), Outcome 8 CCPT‐II No. of commissions.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 1 Trail Making Test A (seconds)." data-id="CD009221-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 1 Trail Making Test A (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 2 Trail Making Test B (seconds)." data-id="CD009221-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 2 Trail Making Test B (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 3 Trail Making Test C (seconds)." data-id="CD009221-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 3 Trail Making Test C (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 4 Trail Making Test D (seconds)." data-id="CD009221-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 4 Trail Making Test D (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 5 WAIS‐III Digit Symbol Coding." data-id="CD009221-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 5 WAIS‐III Digit Symbol Coding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 6 WAIS‐III Digit‐Span." data-id="CD009221-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 6 WAIS‐III Digit‐Span.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 7 FAS Verbal Fluency (total words)." data-id="CD009221-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 (−)‐OSU6162 vs placebo (4 weeks), Outcome 7 FAS Verbal Fluency (total words). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 1 CDR Power of Attention (Milliseconds)." data-id="CD009221-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 1 CDR Power of Attention (Milliseconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 2 CDR Continuity of Attention (% accuracy)." data-id="CD009221-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 2 CDR Continuity of Attention (% accuracy). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 3 CDR Efficiency (COA/POA, % accuracy/millisecond)." data-id="CD009221-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 3 CDR Efficiency (COA/POA, % accuracy/millisecond). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 4 Stroop Interference Trial 4." data-id="CD009221-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 4 Stroop Interference Trial 4. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 5 Adult ADHD Self‐Report Scale (ASRS‐v1.1.)." data-id="CD009221-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Atomoxetine vs placebo (2 weeks), Outcome 5 Adult ADHD Self‐Report Scale (ASRS‐v1.1.). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 1 HVLT‐total word recall." data-id="CD009221-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 1 HVLT‐total word recall.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 2 HVLT‐delayed recall component retention, %." data-id="CD009221-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 2 HVLT‐delayed recall component retention, %. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 3 HVLT–recognition discriminant index." data-id="CD009221-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 3 HVLT–recognition discriminant index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 4 CANTAB RVIP’A." data-id="CD009221-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 4 CANTAB RVIP’A.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 5 CANTAB–SWM, total errors." data-id="CD009221-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 5 CANTAB–SWM, total errors.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 6 CANTAB RVIP, mean latency, ms." data-id="CD009221-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 6 CANTAB RVIP, mean latency, ms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 7 CANTAB‐RT, simple reaction time, ms." data-id="CD009221-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 7 CANTAB‐RT, simple reaction time, ms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 8 CANTAB‐PAL, total errors." data-id="CD009221-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 8 CANTAB‐PAL, total errors.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 9 COWA–semantic association fluency." data-id="CD009221-fig-0039" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 9 COWA–semantic association fluency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 10 Trail Making Test A (seconds)." data-id="CD009221-fig-0040" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 10 Trail Making Test A (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 11 Trail Making Test B (seconds)." data-id="CD009221-fig-0041" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 11 Trail Making Test B (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 12 WAIS‐III‐DS scaled score." data-id="CD009221-fig-0042" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Rivastigmine vs placebo (12 weeks), Outcome 12 WAIS‐III‐DS scaled score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Acceptability of treatment, Outcome 1 Modafinil vs placebo." data-id="CD009221-fig-0043" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Acceptability of treatment, Outcome 1 Modafinil vs placebo.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Acceptability of treatment, Outcome 2 Rivastigmine vs placebo." data-id="CD009221-fig-0044" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Acceptability of treatment, Outcome 2 Rivastigmine vs placebo.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Acceptability of treatment, Outcome 3 (‐)‐OSU6162 vs placebo." data-id="CD009221-fig-0045" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Acceptability of treatment, Outcome 3 (‐)‐OSU6162 vs placebo.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Acceptability of treatment, Outcome 4 Atomoxetine vs placebo." data-id="CD009221-fig-0046" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Acceptability of treatment, Outcome 4 Atomoxetine vs placebo.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 1 Dizziness." data-id="CD009221-fig-0047" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 1 Dizziness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 2 Dysgeusia." data-id="CD009221-fig-0048" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 2 Dysgeusia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 3 Dyspepsia." data-id="CD009221-fig-0049" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 3 Dyspepsia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 4 Fatigue." data-id="CD009221-fig-0050" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 4 Fatigue.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 5 Insomnia." data-id="CD009221-fig-0051" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 5 Insomnia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 6 Memory impairment." data-id="CD009221-fig-0052" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 6 Memory impairment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 7 Nasopharyngitis." data-id="CD009221-fig-0053" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 7 Nasopharyngitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 8 Nausea." data-id="CD009221-fig-0054" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 8 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 9 Weight loss." data-id="CD009221-fig-0055" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 9 Weight loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-007-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-007-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Modafinil vs placebo adverse events, Outcome 10 Unknown." data-id="CD009221-fig-0056" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.10</div> <div class="figure-caption"> <p>Comparison 7 Modafinil vs placebo adverse events, Outcome 10 Unknown.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-007-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (−)‐OSU6162 vs placebo adverse events, Outcome 1 Nausea." data-id="CD009221-fig-0057" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 (−)‐OSU6162 vs placebo adverse events, Outcome 1 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 1 Headache." data-id="CD009221-fig-0058" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 1 Headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 2 Dry mouth." data-id="CD009221-fig-0059" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 2 Dry mouth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 3 Globus pharyngeus." data-id="CD009221-fig-0060" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 3 Globus pharyngeus.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 4 Hypertension." data-id="CD009221-fig-0061" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 4 Hypertension.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 5 Insomnia." data-id="CD009221-fig-0062" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 5 Insomnia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 6 Irritable bowl." data-id="CD009221-fig-0063" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 6 Irritable bowl.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 7 Loss of appetite." data-id="CD009221-fig-0064" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 7 Loss of appetite.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 8 Nasal congestion." data-id="CD009221-fig-0065" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.8</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 8 Nasal congestion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 9 Shoulder pain." data-id="CD009221-fig-0066" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.9</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 9 Shoulder pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-009-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-009-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Atomoxetine vs placebo adverse events, Outcome 10 Urinary retention." data-id="CD009221-fig-0067" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.10</div> <div class="figure-caption"> <p>Comparison 9 Atomoxetine vs placebo adverse events, Outcome 10 Urinary retention.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-009-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Rivastigmine vs placebo adverse events, Outcome 1 Anxiety." data-id="CD009221-fig-0068" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Rivastigmine vs placebo adverse events, Outcome 1 Anxiety.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Rivastigmine vs placebo adverse events, Outcome 2 Arthralgia." data-id="CD009221-fig-0069" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Rivastigmine vs placebo adverse events, Outcome 2 Arthralgia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Rivastigmine vs placebo adverse events, Outcome 3 Diarrhoea." data-id="CD009221-fig-0070" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Rivastigmine vs placebo adverse events, Outcome 3 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Rivastigmine vs placebo adverse events, Outcome 4 Dizziness." data-id="CD009221-fig-0071" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Rivastigmine vs placebo adverse events, Outcome 4 Dizziness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-010-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-010-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Rivastigmine vs placebo adverse events, Outcome 5 Headache." data-id="CD009221-fig-0072" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10 Rivastigmine vs placebo adverse events, Outcome 5 Headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-010-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-010-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Rivastigmine vs placebo adverse events, Outcome 6 Nausea." data-id="CD009221-fig-0073" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10 Rivastigmine vs placebo adverse events, Outcome 6 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-010-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-010-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Rivastigmine vs placebo adverse events, Outcome 7 Upper respiratory tract infection." data-id="CD009221-fig-0074" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.7</div> <div class="figure-caption"> <p>Comparison 10 Rivastigmine vs placebo adverse events, Outcome 7 Upper respiratory tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009221-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/urn:x-wiley:14651858:media:CD009221:CD009221-CMP-010-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_t/tCD009221-CMP-010-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Rivastigmine vs placebo adverse events, Outcome 8 Vomiting." data-id="CD009221-fig-0075" src="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.8</div> <div class="figure-caption"> <p>Comparison 10 Rivastigmine vs placebo adverse events, Outcome 8 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/media/CDSR/CD009221/image_n/nCD009221-CMP-010-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009221-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pharmacological agents compared to placebo for chronic cognitive impairment in traumatic brain injury</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Modafanil, (−)‐OSU6162, atomoxetine or rivastigmine compared to placebo for chronic cognitive impairment in traumatic brain injury</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with chronic cognitive impairment in traumatic brain injury<br/> <b>Settings:</b> Inpatient or community<br/> <b>Intervention:</b> Drug treatment<br/> <b>Comparison:</b> Placebo (2 to 10 weeks) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Effect of drug treatment for people with cognitive impairment in traumatic brain injury</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cognitive performance on psychometric tests</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The majority of sub‐tests showed no difference between treatment and placebo.</p> <p>Superiority over placebo was shown in one measure in <a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a> and several measures in <a href="./references#CD009221-bbs2-0002" title="JohanssonB , CarlssonA , CarlssonMA , KarlssonM , NilssonMKL , Nordquist‐BrandtE , et al. Placebo‐controlled cross‐over study of the monoaminergic stabiliser (‐)‐OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica2012;24(5):266‐74. ">Johansson 2012</a> and <a href="./references#CD009221-bbs2-0005" title="JohanssonB , WentzelA‐P , AndréllP , MannheimerC , RönnbäckL . Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury. Brain Injury2015;29(6):758‐65. ">Johansson 2015</a>. However, interpretation of these findings are cautioned. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>274 (4 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data synthesis was not possible due to the heterogeneity of studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical global improvement</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>A single study reported no difference between treatment and placebo.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p>low<sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data synthesis was not possible as only one study reported a measure on clinical global improvement. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Acceptability</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No differences between treatment and placebo were found.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274(4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>very low<sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data synthesis was not possible due to the heterogeneity of studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Safety</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>More nausea was reported in participants receiving rivastigmine than placebo (<a href="./references#CD009221-bbs2-0004" title="SilverJM , KoumarasB , ChenM , MirskiD , PotkinSG , ReyesP , et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology2006;67(5):748‐55. ">Silver 2006</a>). No other differences were found. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p>very low<sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data synthesis was not possible due to the heterogeneity of studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No deaths were reported by any study.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not estimable.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> downgraded one level due to serious indirectness, as two of four studies did not investigate cognitive impairment as a primary outcome </p> <p><sup>2</sup> downgraded one level due to serious inconsistency, due to wide variance of point estimates. </p> <p><sup>3</sup> downgraded one level due to serious imprecision, as the total population size was less than 400. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pharmacological agents compared to placebo for chronic cognitive impairment in traumatic brain injury</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/full#CD009221-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Modafinil vs placebo (4 weeks)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 SF‐12 Physical <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.18 [‐6.34, 1.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 SF‐12 Mental <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [‐2.84, 6.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 ImPACT verbal memory composite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [‐4.42, 7.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 ImPACT visual memory composite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐6.52, 7.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 ImPACT visual motor speed composite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.45 [‐6.48, ‐0.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 ImPACT reaction time composite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.04, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 CCPT‐II No. of omissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.57 [‐3.59, 36.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 CCPT‐II No. of commissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [‐1.75, 5.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Modafinil vs placebo (4 weeks)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Modafinil vs placebo (10 weeks)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 SF‐12 Physical <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐5.46, 4.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 SF‐12 Mental <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [‐4.28, 5.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 ImPACT verbal memory composite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.11 [‐1.37, 9.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 ImPACT visual memory composite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.61 [‐8.97, 5.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 ImPACT visual motor speed composite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.44 [‐4.61, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 ImPACT reaction time composite  <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.08, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 CCPT‐II No. of omissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.67 [‐4.36, 35.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 CCPT‐II No. of commissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.96 [‐0.47, 6.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Modafinil vs placebo (10 weeks)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">(−)‐OSU6162 vs placebo (4 weeks)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Trail Making Test A (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.20 [‐12.19, ‐6.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Trail Making Test B (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.20 [‐7.81, ‐4.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Trail Making Test C (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>28.4 [‐11.39, 68.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Trail Making Test D (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>53.5 [36.76, 70.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 WAIS‐III Digit Symbol Coding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.6 [6.47, 10.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 WAIS‐III Digit‐Span <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐5.17, 7.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 FAS Verbal Fluency (total words) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.63 [‐27.30, 6.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">(−)‐OSU6162 vs placebo (4 weeks)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Atomoxetine vs placebo (2 weeks)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 CDR Power of Attention (Milliseconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.31 [‐66.81, 77.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 CDR Continuity of Attention (% accuracy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐1.94, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 CDR Efficiency (COA/POA, % accuracy/millisecond) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [‐3.10, 4.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Stroop Interference Trial 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐2.27, 2.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adult ADHD Self‐Report Scale (ASRS‐v1.1.) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.19 [‐5.63, 3.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Atomoxetine vs placebo (2 weeks)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Rivastigmine vs placebo (12 weeks)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 HVLT‐total word recall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐1.14, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 HVLT‐delayed recall component retention, % <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [‐5.66, 7.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 HVLT–recognition discriminant index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.78, 0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 CANTAB RVIP’A <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 CANTAB–SWM, total errors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [‐5.85, 7.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 CANTAB RVIP, mean latency, ms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐44.54 [‐88.62, ‐0.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 CANTAB‐RT, simple reaction time, ms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐19.81 [‐59.23, 19.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 CANTAB‐PAL, total errors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.16 [‐10.75, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 COWA–semantic association fluency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐0.97, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Trail Making Test A (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.83 [‐7.38, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Trail Making Test B (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.48 [‐6.31, 13.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 WAIS‐III‐DS scaled score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [‐0.33, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Rivastigmine vs placebo (12 weeks)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Acceptability of treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Modafinil vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.46 [0.22, 88.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Rivastigmine vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.35, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 (‐)‐OSU6162 vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Atomoxetine vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Acceptability of treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Modafinil vs placebo adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.56 [0.43, 29.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Dysgeusia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.46 [0.22, 88.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dyspepsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.46 [0.22, 88.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.44 [0.56, 35.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Insomnia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.67 [0.59, 11.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Memory impairment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.46 [0.22, 88.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Nasopharyngitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.01, 3.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.67 [0.30, 23.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Weight loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.46 [0.22, 88.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Unknown <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.46 [0.22, 88.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Modafinil vs placebo adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">(−)‐OSU6162 vs placebo adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.01, 8.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">(−)‐OSU6162 vs placebo adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Atomoxetine vs placebo adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Dry mouth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.78 [0.27, 126.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Globus pharyngeus <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [0.13, 85.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [0.13, 85.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Insomnia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.78 [0.27, 126.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Irritable bowl <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [0.13, 85.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Loss of appetite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [0.13, 85.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Nasal congestion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [0.13, 85.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Shoulder pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [0.13, 85.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Urinary retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [0.13, 85.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Atomoxetine vs placebo adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009221-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Rivastigmine vs placebo adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.67 [0.47, 158.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Arthralgia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [0.36, 10.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.41 [0.48, 12.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.7 [0.99, 60.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.35, 2.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [1.29, 7.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Upper respiratory tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.17 [0.70, 6.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.7 [0.99, 60.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Rivastigmine vs placebo adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009221.pub2/references#CD009221-tbl-0011">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009221.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009221-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009221-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD009221-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009221\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009221\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009221\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009221\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009221\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IregKd2C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009221.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009221.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009221.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009221.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009221.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729388829"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009221.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729388833"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009221.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918edbadaf0df4a4',t:'MTc0MDcyOTM4OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 